We create unparalleled partnerships with our clients to develop life-changing therapeutics, tests, and processes to support our mission of saving lives through enhanced patient care.
Through our expertise, customization, and scalability, NeoGenomics supports clients in cancer-related market segments, including hospital and private pathology laboratories, office-based oncologists, academic institutions, contract research and pharmaceutical development organizations, and more. We are tirelessly pushing the boundaries and improving our capabilities to provide our partners with the most technologically advanced testing available, integrating the latest clinical evidence and guidelines to advance the care of all patients.
- Leadership
- Board of Directors
- Medical & Scientific
- Scientific Advisory Board
Chris Smith
Chief Executive Officer
Read Bio
Jeff Sherman
Chief Financial Officer
Read Bio
Warren Stone
Chief Commercial Officer
Read Bio
Melody Harris
Chief Operations Officer & President, Informatics
Read Bio
Ali Olivo
Executive Vice President, General Counsel & Business Development
Read Bio
Hutan Hashemi, JD
Chief Compliance Officer
Read Bio
Nathan Montgomery, MD, PhD
Vice President, Medical Services
Read Bio
Gary Passman
Chief Culture Officer
Read Bio
Kareem Saad
Head of Strategy and Transformation
Read Bio